Specialists in Unlicensed Medicine
At Pro Pharmaceuticals Group, we accelerate access to critical treatments when approved options are unavailable or clinically unsuitable. Staying true to our mission of Accelerating Access, Transforming Lives Worldwide, we bridge the gap to meet unmet medical needs, delivering essential unlicensed medicines.
Necesidad clĆnica insatisfecha
ā
Para un paciente con una enfermedad que necesita un tratamiento particular, es posible que no haya un producto disponible comercialmente en Australia disponible para tratar sus necesidades clĆnicas.
ā
Medicamentos sin licencia y programas de acceso administrado
ā
No todos los medicamentos estĆ”n aprobados en todos los paĆses, y puede haber pacientes que necesiten acceder a medicamentos no aprobados en sus paĆses.
ā
Un _cc781905-5cde -3194-bb3b-136bad5cf58d_Medicine (UL) sin licencia en Australia significa que actualmente no cuenta con la aprobaciĆ³n de registro/comercializaciĆ³n (MA) de nuestro regulador, la AdministraciĆ³n de productos terapĆ©uticos (TGA). Sin embargo, el medicamento en particular puede tener un registro/aprobaciĆ³n de comercializaciĆ³n actual en otra regiĆ³n del mundo, como el Reino Unido, EE. UU., Europa u otra regiĆ³n.
ā
Programa de Acceso Administrado (MAP) es un tĆ©rmino que usamos para definir un acuerdo mĆ”s formalizado con un Patrocinador. El suministro y la distribuciĆ³n de productos en particular se adaptarĆan a las solicitudes de los Patrocinadores. Esto puede adaptarse a una etapa del ciclo de vida previa a la aprobaciĆ³n, por ejemplo.
ā
ĀæPor quĆ© no estĆ” disponible en mi regiĆ³n?
ā
Producto quizĆ”s en desarrollo clĆnico aĆŗn no aprobado (tiempo)
Post ensayo clĆnico pero sin proceder a la aprobaciĆ³n (sin proceder a la comercializaciĆ³n en la regiĆ³n)
Puede estar aprobado en otro paĆs, por ejemplo, EE. UU., Europa o JapĆ³n.
Puede haber escasez en Australia
ā
Why partner with Pro Pharmaceuticals Group?
Experience
Managed Access Programs
(MAPS) for Healthcare providers
With extensive experience and a patient-centric approach, Pro Pharmaceuticals Group delivers reliable access to essential medicines. Our global network connects with trusted suppliers to ensure the quality and availability of treatments. By prioritising timely, effective solutions, we help achieve the best possible outcomes for patients.
Partnering with Pro Pharmaceuticals Group provides healthcare providers and patients a dependable lifeline to critical treatments when they need them most.
Our 24/7 support ensures you receive immediate assistance whenever you need it. You can enjoy access to a broad selection of medicines from our expansive global network.
Additionally, you can rely on us as a trusted source, being a 100% Australian-owned company committed to social responsibility.
Managed Access Programs
(MAPS) for Suppliers
Collaborate with us
We forge trusted partnerships by establishing direct relationships with manufacturers, adhering to strict quality standards. Our exclusive access secures supply agreements that ensure a consistent supply of medicines.
We maintain global excellence by collaborating with validated, GDP-compliant licensed global wholesalers.
āWe provide:
-
Custom Solutions: Tailored assistance to healthcare professionals for unresolved medical needs.
-
In-depth Support: Comprehensive product information, streamlined logistics, and assistance with TGA compliance.
-
Direct Delivery: We manage importation and directly supply hospitals, simplifying access through approved channels.